Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Añadir filtros








Intervalo de año
1.
Clinical Psychopharmacology and Neuroscience ; : 70-72, 2017.
Artículo en Inglés | WPRIM | ID: wpr-41574

RESUMEN

Wolfram syndrome is a relatively unexplored entity in clinical psychiatry. Historically, the discovery of a specific WFS1 gene had generated huge fanfare regarding specific genetic causations of psychiatric disorders. While the initial enthusiasm has faded now, association of Wolfram syndrome with psychiatric illnesses like schizophrenia, psychosis and suicidal behavior still remain important for understanding biological underpinnings of such disorders. We report a case of Wolfram syndrome presenting with multiple manic episodes, discuss possible genetic underpinnings for the affective symptoms and then discuss certain issues regarding management.


Asunto(s)
Síntomas Afectivos , Trastorno Bipolar , Comorbilidad , Trastornos Psicóticos , Esquizofrenia , Síndrome de Wolfram
2.
Clinical Psychopharmacology and Neuroscience ; : 311-313, 2016.
Artículo en Inglés | WPRIM | ID: wpr-108189

RESUMEN

Dermatitis artefacta lies in a gray zone, between the specialities of psychiatry and dermatology. The condition could mimic a number of other lesions and therefore is a source of much confusion in clinical practice. Here, we describe a case of dermatitis artefacta in an 11-years old girl, which resembled self-harming behavior in Borderline personality disorder. We then discuss how the two could be differentiated and why this becomes imperative while dealing with such cases.


Asunto(s)
Femenino , Humanos , Trastorno de Personalidad Limítrofe , Dermatitis , Dermatología , Conducta Autodestructiva , Piel
3.
Clinical Psychopharmacology and Neuroscience ; : 316-318, 2015.
Artículo en Inglés | WPRIM | ID: wpr-209620

RESUMEN

While fluoxetine (FXT) is a frequently prescribed selective serotonin reuptake inhibitor (SSRI), with few major side-effects; altered serotonergic transmissions in hypothalamic pathways might lead to a distressing, and often embarrassing, manifestation of galactorrhea by altering prolactin release in those on FXT. We report here a case of FXT-induced hyperprolactinemic galactorrhea developing late into treatment on a stable regimen, who responded well to subsequent replacement with sertraline. Based on present finding, we suggest that while SSRIs may share similar mechanisms of action, there exist individual differences in their effects on prolactin secretion pathways.


Asunto(s)
Femenino , Embarazo , Fluoxetina , Galactorrea , Hiperprolactinemia , Individualidad , Trastorno Obsesivo Compulsivo , Prolactina , Vías Secretoras , Serotonina , Inhibidores Selectivos de la Recaptación de Serotonina , Sertralina
4.
Clinical Psychopharmacology and Neuroscience ; : 327-327, 2015.
Artículo en Inglés | WPRIM | ID: wpr-209616

RESUMEN

No abstract available.


Asunto(s)
Enfermedad de Alzheimer , Países en Desarrollo , Prevención Primaria
5.
Clinical Psychopharmacology and Neuroscience ; : 222-223, 2015.
Artículo en Inglés | WPRIM | ID: wpr-121251

RESUMEN

No abstract available.


Asunto(s)
Paroxetina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA